Table 3 Demographic, clinical, and baseline laboratory data of survivors and non-survivors

General characteristics

 Age, month

12 (4 – 48)

18 (6.5 – 102)

0.19

 Male sex

20 (44.4%)

11 (44%)

0.97

 Weight, Kg

8.6 (5.5 – 12.8)

8 (6.3 – 21)

0.32

 Category

 Sepsis

35 (76.1%)

6 (25%)

 < 0.001^*

 Severe sepsis

7 (15.6%)

7 (28%)

 Septic shock

4 (8.9%)

11 (44%)

Complex chronic condition^**

15 (32.6%)

11 (45.8%)

0.28

 Malnutrition

21 (45.7%)

14 (58.3%)

0.31

Illness severity

 ARDS^a

1 (2.2%)

8 (32%)

0.001^*

 Mechanical ventilation

8 (17.8%)

22 (88%)

 < 0.001^*

 Ventilator-free days

7 (4.5 – 10)

1 (0 – 6)

 < 0.001^*

 HAI^b

6 (13.3%)

12 (48%)

0.001^*

 Vasoactive medications

4 (8.9%)

17 (68%)

 < 0.001^*

 Vasoactive infusion days

0 (0 – 0)

4 (0 – 6)

 < 0.001^*

 Vasoactive-inotropic score (day 1)

0 (0 – 0)

10 (0 – 25)

 < 0.001^*

 Vasoactive-inotropic score (day 2)

0 (0 – 0)

20 (0 – 30)

 < 0.001^*

 Need for renal replacement therapy

2 (4.3%)

3 (12.5%)

0.33

 MODS^c (day1)

6 (13.3%)

14 (56%)

 < 0.001^*

 MODS (day 3)

2 (4.4%)

14 (56%)

 < 0.001^*

 PICU^d stay, days

7 (5 – 11.5)

7 (4 – 20.5)

0.79

 PIM2^e mortality risk%

2.2 (1.4 – 6.2)

7.1 (1.8 – 21.1)

0.003^*

 pSOFA^f score (1^st day)

4 (3 – 5.8)

8 (5 – 11.5)

 < 0.001^*

Laboratory values on admission

 CRP^g, mg/dL

24 (7.8 – 52.5)

32 (6 – 87.5)

0.72

 Hemoglobin, g/dL

10.3 (9.6 – 11.3)

10 (8.8 – 10.8)

0.29

 WBC^h, 1000/uL

15.7 (9.9 – 20.0)

13.1 (4.1 – 22.4)

0.52

 ANCⁱ, 1000/uL

8.9 (5.9 – 13.5)

9.9 (2.3 – 16.1)

0.97

 Platelets, 1000/uL

349.5 (175.5 – 424.5)

210.5 (82.8 – 346.5)

0.024^*

 Creatinine, mg/dL

0.55 (0.4 – 0.7)

0.65 (0.5 – 1.28)

0.14

 ALT^j, U/L

21 (15 – 39.3)

26.5 (18 – 99.5)

0.13

 ADAMTS-13 ^k, ng/mL

2.45 (0.98 – 3.50)

0.9 (0.80 – 1.18)

 < 0.001^*